| Mechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury | Mechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury: Effects of Ginsenoside Derivatives on the Improvement of Delayed Neutrophil Apoptosis | NCT04607434 |
| A randomized, open-label, single-dose, crossover study to compare the safety, tolerability and pharmacokinetics of ginsenosides after oral administrations of fermented Red ginseng concentrate and Red ginseng concentrate in healthy volunteers | A randomized, open-label, single-dose, crossover study to compare the safety, tolerability and pharmacokinetics of ginsenosides after oral administrations of fermented Red ginseng concentrate and Red ginseng concentrate in healthy volunteers | KCT0006791 |
| A human trial to evaluate effects of ginsenoside fortified red ginseng on immune function and fatigue recovery | A single-center, randomized, double-blind, placebo-controlled pilot human trial to evaluate effects of 4-week administration of ginsenoside fortified red ginseng on immune function and fatigue recovery | KCT0001647 |
| Clinical studies on Ginsenoside C-K | Study on tolerability and pharmacokinetics of Ginsenoside C-K tablet in healthy volunteers after a single dose | ChiCTR-TRC-14004824 |
| Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke | Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Multicenter Trial | NCT00815763 |
| Ginsenoside Improve Metabolic Syndrome | Effects of Ginsenoside Supplementation on Insulin Resistance and Cardiometabolic Risk Factors in Men With Metabolic Syndrome: a Randomized Controlled Trial. | NCT02034136 |
| Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides | Dissolution and Pharmacokinetic of Ginsenosides Released From Cyclodextrin Based Chewable Tablets: a Comparative, Randomized, Crossover, Open-label Study in Healthy Human Subjects. | NCT04932265 |
| A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC) | A Phase?a, Placebo Parallel Control, Central Randomized, Double Blind, Dosage Exploring and Multi-Center Study to Evaluate the Efficacy and Safety of Ginsenoside H Dripping Pills in Patients With Advanced NSCLC (Syndrome Of Qi-Deficiency) | NCT02714608 |
| Ginsenoside-Rd for Acute Ischemic Stroke | Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-blind, Placebo-controlled, Phase ?, Multicenter Trial | NCT00591084 |
| Efficacy and safety of high Ginsenoside F2 extract on improvement of Liver function | A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of high Ginsenoside F2 extract on improvement of Liver function | KCT0005511 |
| To study relative bioavailability between Ginsenoside Compound K solubilizing tablet(50mg/ tablet,25 mg/ tablet) and Ginsenoside Compound K tablet (50mg/ tablet) and pharmacokinetics parameters of Ginsenoside Compound K solubilizing tablet(50mg/ tablet,25 mg/ tablet) in Chinese healthy population us | To study relative bioavailability between Ginsenoside Compound K solubilizing tablet(50mg/ tablet,25 mg/ tablet) and Ginsenoside Compound K tablet (50mg/ tablet) and pharmacokinetics parameters of Ginsenoside Compound K solubilizing tablet(50mg/ tablet,25 mg/ tablet) in Chinese healthy population us | ChiCTR-TTRCC-14004177 |
| A randomized double-blind controlled trial study of personalized interventions for the improvement of dyslipidemia by ginsenosides | A randomized double-blind controlled trial study of personalized interventions for the improvement of dyslipidemia by ginsenosides | ChiCTR2400086584 |
